Both in Pharmaceuticals
Alto Neuroscience vs Alumis
Over the past year ANRO returned +87.0% and ALMS returned +45.4%; their daily moves had a correlation of 0.10.
ANRO +87.0% ALMS +45.4%Growth of $1, one year, split-adjusted
| Metric | ANRO | ALMS |
|---|---|---|
| Price | $22.91 | $7.00 |
| Market cap | $898.8M | $905.4M |
| Today | −1.23% | +5.35% |
| 1 month | −13.8% | −4.0% |
| 6 months | −5.7% | −69.4% |
| Year to date | +28.7% | −28.3% |
| 1 year | +87.0% | +45.4% |
| Revenue growth (YoY) | — | −37.7% |
| Gross margin | — | 100.0% |
| Net margin | — | −8557.2% |
| P/E (TTM) | — | — |
| Price / sales | — | 122.4× |
| Net cash | $225.1M | $502.3M |
| Dividend yield | — | — |
| Volatility (60d) | 55.7% | 180.1% |
| Short % of float | 20.0% | 11.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).